ER stress in retinal degeneration: A target for rational therapy?

Trends in Molecular Medicine

Volumn 17, Issue 8, 2011, Pages 442-451

  Griciuc, Ana ^a,b   Aron, Liviu ^c   Ueffing, Marius ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RHODOPSIN;

AUTOPHAGY; CELL DEATH; CELL FATE; CONFORMATION; ENDOPLASMIC RETICULUM STRESS; GENE MUTATION; HOMEOSTASIS; HUMAN; LYSOSOME; MODULATION; MOLECULAR MECHANICS; NONHUMAN; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; RETINA DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR TARGETED THERAPY; MUTATION; PROTEOSTASIS DEFICIENCIES; RETINAL DEGENERATION; RETINITIS PIGMENTOSA; RHODOPSIN; STRESS, PHYSIOLOGICAL;

EID: 80955178939     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.04.002     Document Type: Review

References (70)

1. Rutkowski D.T., Hegde R.S. Regulation of basal cellular physiology by the homeostatic unfolded protein response. J. Cell Biol. 2010, 189:783-794.
2. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8:519-529.
3. Kim I., et al. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 2008, 7:1013-1030.
4. Mendes H.F., et al. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 2005, 11:177-185.
5. Hartong D.T., et al. Retinitis pigmentosa. Lancet 2006, 368:1795-1809.
6. Daiger S.P., et al. Perspective on genes and mutations causing retinitis pigmentosa. Arch. Ophthalmol. 2007, 125:151-158.
7. Kennan A., et al. Light in retinitis pigmentosa. Trends Genet. 2005, 21:103-110.
8. Sancho-Pelluz J., et al. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol. Neurobiol. 2008, 38:253-269.
9. Dryja T.P., et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990, 343:364-366.
10. Wang T., Montell C. Phototransduction and retinal degeneration in Drosophila. Pflugers Arch. 2007, 454:821-847.
11. Galy A., et al. Rhodopsin maturation defects induce photoreceptor death by apoptosis: a fly model for RhodopsinPro23His human retinitis pigmentosa. Hum. Mol. Genet. 2005, 14:2547-2557.
12. Griciuc A., et al. Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet. 2010, 6:e1001075.
13. Tam B.M., Moritz O.L. Characterization of rhodopsin P23H-induced retinal degeneration in a Xenopus laevis model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 2006, 47:3234-3241.
14. Olsson J.E., et al. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 1992, 9:815-830.
15. Wu T.H., et al. Opsin localization and rhodopsin photochemistry in a transgenic mouse model of retinitis pigmentosa. Neuroscience 1998, 87:709-717.
16. Frederick J.M., et al. Mutant rhodopsin transgene expression on a null background. Invest. Ophthalmol. Vis. Sci. 2001, 42:826-833.
17. Sakami S., et al. Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J. Biol. Chem. 2011, 286:10551-10567.
18. Fanelli F., Seeber M. Structural insights into retinitis pigmentosa from unfolding simulations of rhodopsin mutants. FASEB J. 2010, 24:3196-3209.
19. Krebs M.P., et al. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J. Mol. Biol. 2010, 395:1063-1078.
20. Tam B.M., Moritz O.L. The role of rhodopsin glycosylation in protein folding, trafficking, and light-sensitive retinal degeneration. J. Neurosci. 2009, 29:15145-15154.
21. Kosmaoglou M., et al. Molecular chaperones and photoreceptor function. Prog. Retin. Eye Res. 2008, 27:434-449.
22. Anukanth A., Khorana H.G. Structure and function in rhodopsin. Requirements of a specific structure for the intradiscal domain. J. Biol. Chem. 1994, 269:19738-19744.
23. Chapple J.P., Cheetham M.E. The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation. J. Biol. Chem. 2003, 278:19087-19094.
24. Noorwez S.M., et al. Calnexin improves the folding efficiency of mutant rhodopsin in the presence of pharmacological chaperone 11-cis-retinal. J. Biol. Chem. 2009, 284:33333-33342.
25. Kosmaoglou M., Cheetham M.E. Calnexin is not essential for mammalian rod opsin biogenesis. Mol. Vis. 2008, 14:2466-2474.
26. Kosmaoglou M., et al. A dual role for EDEM1 in the processing of rod opsin. J. Cell Sci. 2009, 122:4465-4472.
27. Hetz C., Glimcher L.H. Fine-tuning of the unfolded protein response: assembling the IRE1alpha interactome. Mol. Cell 2009, 35:551-561.
28. Merksamer P.I., Papa F.R. The UPR and cell fate at a glance. J. Cell Sci. 2010, 123:1003-1006.
29. Mendes C.S., et al. ER stress protects from retinal degeneration. EMBO J. 2009, 28:1296-1307.
30. Ryoo H.D., et al. Unfolded protein response in a Drosophila model for retinal degeneration. EMBO J. 2007, 26:242-252.
31. Lin J.H., et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 2007, 318:944-949.
32. Gorbatyuk M.S., et al. Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5961-5966.
33. Shore G.C., et al. Signaling cell death from the endoplasmic reticulum stress response. Curr. Opin. Cell Biol. 2011, 23:143-149.
34. Behrman S., et al. A CHOP-regulated microRNA controls rhodopsin expression. J. Cell Biol. 2011, 192:919-927.
35. Illing M.E., et al. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 2002, 277:34150-34160.
36. Saliba R.S., et al. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J. Cell Sci. 2002, 115:2907-2918.
37. Griciuc A., et al. Clearance of Rhodopsin(P23H) aggregates requires the ERAD effector VCP. Biochim. Biophys. Acta 2010, 1803:424-434.
38. Koike M., et al. Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression. J. Biol. Chem. 2010, 285:21736-21749.
39. Egger L., et al. Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ. 2007, 14:1172-1180.
40. Kang M.J., Ryoo H.D. Suppression of retinal degeneration in Drosophila by stimulation of ER-associated degradation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17043-17048.
41. Mizushima N., et al. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
42. Ogata M., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell. Biol. 2006, 26:9220-9231.
43. Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
44. Mendes H.F., Cheetham M.E. Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa. Hum. Mol. Genet. 2008, 17:3043-3054.
45. Wang T., et al. TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J. Cell Biol. 2009, 186:703-711.
46. Rutkowski D.T., et al. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol. 2006, 4:e374.
47. Noorwez S.M., et al. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem. 2003, 278:14442-14450.
48. Shintani K., et al. Review and update: current treatment trends for patients with retinitis pigmentosa. Optometry 2009, 80:384-401.
49. Ohgane K., et al. Retinobenzaldehydes as proper-trafficking inducers of folding-defective P23H rhodopsin mutant responsible for retinitis pigmentosa. Bioorg. Med. Chem. 2010, 18:7022-7028.
50. Noorwez S.M., et al. A high-throughput screening method for small-molecule pharmacologic chaperones of misfolded rhodopsin. Invest. Ophthalmol. Vis. Sci. 2008, 49:3224-3230.
51. Tabata Y., et al. Vaticanol B, a resveratrol tetramer, regulates endoplasmic reticulum stress and inflammation. Am. J. Physiol. Cell Physiol. 2007, 293:C411-418.
52. Malhotra J.D., et al. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18525-18530.
53. Farrar G.J., et al. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 2002, 21:857-864.
54. O'Reilly M., et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am. J. Hum. Genet. 2007, 81:127-135.
55. Mao H., et al. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa. Hum. Gene Ther. 2011, 22:567-575.
56. Wiseman R.L., et al. Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol. Cell 2010, 38:291-304.
57. Pincus D., et al. BiP binding to the ER-stress sensor Ire1 tunes the homeostatic behavior of the unfolded protein response. PLoS Biol. 2010, 8:e1000415.
58. Sokka A.L., et al. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J. Neurosci. 2007, 27:901-908.
59. Boyce M., et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005, 307:935-939.
60. Yang L.P., et al. Activation of endoplasmic reticulum stress in degenerating photoreceptors of the rd1 mouse. Invest. Ophthalmol. Vis. Sci. 2007, 48:5191-5198.
61. Datta R., et al. Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3437-3442.
62. Yang L.P., et al. Endoplasmic reticulum stress is activated in light-induced retinal degeneration. J. Neurosci. Res. 2008, 86:910-919.
63. Libby R.T., Gould D.B. Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration. Adv. Exp. Med. Biol. 2010, 664:403-409.
64. Nedelsky N.B., et al. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim. Biophys. Acta 2008, 1782:691-699.
65. Carvalho P., et al. Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 2006, 126:361-373.
66. Vembar S.S., Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 2008, 9:944-957.
67. Korennykh A.V., et al. The unfolded protein response signals through high-order assembly of Ire1. Nature 2009, 457:687-693.
68. Wiseman R.L., et al. An adaptable standard for protein export from the endoplasmic reticulum. Cell 2007, 131:809-821.
69. Nagai A., et al. USP14 inhibits ER-associated degradation via interaction with IRE1alpha. Biochem. Biophys. Res. Commun. 2009, 379:995-1000.
70. Rajan R.S., Kopito R.R. Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J. Biol. Chem. 2005, 280:1284-1291.